Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKACA | P17612 | 1/20 | 0.43 |
| ▸ | PRKACG | P22612 | 1/20 | 0.43 |
| ▸ | PRKACB | P22694 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.42 |
| ▸ | DRD3 | P35462 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27700096 | 0.87 | PRKACA (0.42) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL27700080 | 0.82 | PRKACA (0.41) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL28900236 | 0.77 | DRD2 (0.46) | DRD2DRD3HTR1A | |
| SCHEMBL27682789 | 0.76 | PRKACA (0.43) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL27700074 | 0.76 | KDM4E (0.43) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL27705039 | 0.76 | KDM4E (0.43) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL6389994 | 0.74 | DRD2 (0.68) | PRKACAPRKACGPRKACBDRD2DRD3 | |
| SCHEMBL18399274 | 0.73 | DRD2 (0.43) | DRD2DRD3HTR1A | |
| SCHEMBL18399078 | 0.73 | SLC6A3 (0.46) | — | |
| SCHEMBL27482516 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101010317-A | 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer | ASTRAZENECA AB (SE) | 2007-08-01 | — | — | CN | disclosed |